CRDL.TO · Cardiol Therapeutics Inc.
Canada · RS rating 32 · As of 2026-10-14
| Price | 1.60 CAD |
|---|---|
| 1-day change | -6.4% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 2 / 45 / 54 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 32 / 28 / 52 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | +50.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +49.4% |
| Market cap (USD) | $152.0M |